BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34749333)

  • 1. THE FAMILIAL HYPOCALCIURIC HYPERCALCEMIA PRESENTED WITH ADVANCED HYPERCALCEMIA AND EXTREMELY HIGH PARATHORMON LEVELS (CASE REPORT).
    Cengiz H; Varim C; Demirci T; Cetin S; Karacaer C; Koçer H
    Georgian Med News; 2021 Oct; (319):108-111. PubMed ID: 34749333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parathyroid hormone-dependent familial hypercalcemia with low measured PTH levels and a presumptive novel pathogenic mutation in CaSR.
    Mahajan A; Buse J; Kline G
    Osteoporos Int; 2020 Jan; 31(1):203-207. PubMed ID: 31641801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population.
    Stratta P; Merlotti G; Musetti C; Quaglia M; Pagani A; Izzo C; Radin E; Airoldi A; Baorda F; Palladino T; Leone MP; Guarnieri V
    Nephrol Dial Transplant; 2014 Oct; 29(10):1902-9. PubMed ID: 25104082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of familial hypocalciuric hypercalcemia type 1 due to CASR p.Pro55Leu mutation.
    Sumida A; Iizuka K; Kato T; Liu Y; Kubota S; Kubota-Okamoto S; Sakurai T; Imaizumi T; Takahashi Y; Mizuno M; Takao K; Hirota T; Suwa T; Horikawa Y; Yamamoto M; Seino Y; Suzuki A; Yabe D
    BMC Endocr Disord; 2022 Jun; 22(1):164. PubMed ID: 35733207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and parathyroid hormone in familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Christensen SE; Nissen PH; Vestergaard P; Heickendorff L; Rejnmark L; Brixen K; Mosekilde L
    Eur J Endocrinol; 2008 Dec; 159(6):719-27. PubMed ID: 18787045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary hyperparathyroidism in a patient with familial hypocalciuric hypercalcaemia due to a novel mutation in the calcium-sensing receptor gene.
    Egan AM; Ryan J; Aziz MA; O'Dwyer TP; Byrne MM
    J Bone Miner Metab; 2013 Jul; 31(4):477-80. PubMed ID: 23081733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation of the calcium-sensing receptor gene in a German subject with familial hypocalciuric hypercalcemia and primary hyperparathyroidism.
    Papadakis M; Meurer N; Margariti T; Meyer A; Weyerbrock N; Dotzenrath C
    Hormones (Athens); 2016 Oct; 15(4):557-559. PubMed ID: 28222409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concomitant familial hypocalciuric hypercalcemia and single parathyroid adenoma: a case report.
    Marstrand SD; Tofteng CL; Jarløv A; Borgwardt L; Schwarz P
    J Med Case Rep; 2021 Sep; 15(1):471. PubMed ID: 34556169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial Hypocalciuric Hypercalcemia Types 1 and 3 and Primary Hyperparathyroidism: Similarities and Differences.
    Vargas-Poussou R; Mansour-Hendili L; Baron S; Bertocchio JP; Travers C; Simian C; Treard C; Baudouin V; Beltran S; Broux F; Camard O; Cloarec S; Cormier C; Debussche X; Dubosclard E; Eid C; Haymann JP; Kiando SR; Kuhn JM; Lefort G; Linglart A; Lucas-Pouliquen B; Macher MA; Maruani G; Ouzounian S; Polak M; Requeda E; Robier D; Silve C; Souberbielle JC; Tack I; Vezzosi D; Jeunemaitre X; Houillier P
    J Clin Endocrinol Metab; 2016 May; 101(5):2185-95. PubMed ID: 26963950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A series of clinical cases of familial hypocalciuric hypercalcemia syndrome].
    Krupinova JA; Almaskhanova AA; Eremkina AK; Bibik EE; Vasilyev EV; Mokrysheva NG
    Probl Endokrinol (Mosk); 2020 Oct; 66(5):61-69. PubMed ID: 33369373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary hyperparathyroidism and familial hypocalciuric hypercalcemia: relationships and clinical implications.
    Eldeiry LS; Ruan DT; Brown EM; Gaglia JL; Garber JR
    Endocr Pract; 2012; 18(3):412-7. PubMed ID: 22232026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria.
    Mastromatteo E; Lamacchia O; Campo MR; Conserva A; Baorda F; Cinque L; Guarnieri V; Scillitani A; Cignarelli M
    BMC Endocr Disord; 2014 Oct; 14():81. PubMed ID: 25292184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Familial hypocalciuric hypercalcemia and related disorders.
    Lee JY; Shoback DM
    Best Pract Res Clin Endocrinol Metab; 2018 Oct; 32(5):609-619. PubMed ID: 30449544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypocalciuric hypercalcemia in an index male: grey zones of the differential diagnosis from primary hyperparathyroidism in a 13-year clinical follow up.
    Zajíčková K; Dvořáková M; Moravcová J; Včelák J; Goltzman D
    Physiol Res; 2020 Sep; 69(Suppl 2):S321-S328. PubMed ID: 33094630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misleading localization by
    Mukhtar NN; Abouzied MEM; Alqahtani MH; Hammami MM
    BMC Endocr Disord; 2021 Jan; 21(1):20. PubMed ID: 33499837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Familial hypocalciuric hypercalcemia: a new mutation].
    Ubetagoyena Arrieta M; Castaño González L; Pérez de Nanclares Leal G; Arruebarrena Lizarraga D; Imaz Murguiondo M; Areses Trapote R
    An Pediatr (Barc); 2011 Jan; 74(1):47-50. PubMed ID: 21185797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hypercalcemia with similar familial Hypocalciuric hypercalcemia features: a case report and literature review.
    Zahedi M; Hizomi Arani R; Rafati M; Amouzegar A; Hadaegh F
    BMC Endocr Disord; 2021 Nov; 21(1):220. PubMed ID: 34736428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
    Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
    Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism.
    Frank-Raue K; Leidig-Bruckner G; Haag C; Schulze E; Lorenz A; Schmitz-Winnenthal H; Raue F
    Clin Endocrinol (Oxf); 2011 Jul; 75(1):50-5. PubMed ID: 21521328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia.
    Falchetti A; Gozzini A; Terranegra A; Soldati L; Vezzoli G; Leoncini G; Giusti F; Franceschelli F; Masi L; Tanini A; Cavalli L; Brandi ML
    Eur J Endocrinol; 2012 May; 166(5):933-40. PubMed ID: 22315359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.